| 英文别名 |
N-(3,4-Dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)acetamide;N-(3,4-Dimethoxyphenethyl)-3,4-dimethoxybenzeneacetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dimethoxyphenylacetam;N-[2-(3,4-Dimethoxyphenyl)ethyl]-3,4-dimethoxybenzeneacetamide;2-(3,4-dimethoxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide;Phenylacetic amide, N-[2-[3,4-dimethoxyphenyl]ethyl]-3,4-dimethoxy-;N-Homoveratroyl-homoveratrylamin;DTXSID20160857;CHEMBL1875355;NSC-140013;2-(3,4-Dimethoxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide #;Q2M3HW9FTB;SMR000386984;3,4-Dimethoxy-N-[2-(3,4-dimethoxyphenyl)ethyl]benzeneacetamide;AMY36849;Benzeneacetamide,4-dimethoxyphenyl)ethyl]-3,4-dimethoxy-;139-76-4;NSC 140013;AKOS003629969;NCGC00246214-01;NS00024514;MLS001048961;NSC140013;Acetamide, N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-;N-(3,4-Dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl acetamide;Acetamide,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-;N-(3,4-dimethoxyphenylethyl)-2-(3,4-dimethoxyphenyl)acetamide;HMS2270I10;SCHEMBL248400;AE-562/41718249;EINECS 205-374-0;N-(2-[3,4-Dimethoxyphenyl]ethyl)-3,4-dimethoxyphenylacetamide;N-(3,4-Dimethoxyphenethyl)-2-(4,5-dimethoxyphenyl)acetamide;Oprea1_835651;N-(2-(3,4-Dimethoxyphenyl)ethyl)-3,4-dimethoxyphenylacetamide;Benzeneacetamide, N-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dimethoxy-;DB-230923;DB-346052;STL570063;2-(3,4-Dimethoxy-Phenyl)-N-(2-(3,4-Dimethoxy-Phenyl)-Ethyl)-Acetamide;193679-69-5 |
